natgillin/translations-raw huggingface dataset:
NEXGARD SPECTRA kills Dirofilaria immitis larvae up to one month after their transmission by mosquitoes, therefore the product should be administered at regular monthly intervals during the time of the year when vectors are present, starting in the month after the first expected exposure to mosquitoes.
Zdravilo NEXGARD SPECTRA ubija ličinke Dirofilaria immitis (srčne gliste) do enega meseca po njihovem prenosu s komarji, zato je potrebno zdravilo odmerjati redno v mesečnih intervalih v celotnem obdobju izpostavljenosti komarjem, začenši en mesec po prvi izpostavljenosti.
Dogs living in heartworm endemic areas (where heartworm disease is present), or those which have travelled to endemic areas, may be infested with adult heartworms.
Psi ki živijo v endemičnih področjih dirofilarioze (kjer je bolezen srčne gliste prisotna), ali ki potujejo v taka področja, so lahko infestirani s srčno glisto.
Treatment of flea infestations (Ctenocephalides felis and C. canis) in dogs.
Zdravljenje infestacije z bolhami (Ctenocephalides felis and C. canis) pri psih.
Treatment of flea and tick infestations and gastrointestinal nematodes:
Zdravljenje infestacij z bolhami in klopi ter gastrointestinalnimi nematodi:
After treatment of the nematode infestations, further flea and tick treatment should be continued with a monovalent product.
Po zdravljenju infestacij z gastrointestinalnimi nematodi, je potrebno zaščito pred bolhami in klopi nadaljevati z monovalentnim zdravilom.
Dogs living in heartworm endemic areas, or those which have travelled to endemic areas, may be infested with adult heartworms.
Psi ki živijo v endemičnih področjih dirofilarioze, ali ki potujejo v taka področja, so lahko infestirani s srčno glisto.
Afoxolaner kills fleas before egg production and therefore prevents the risk of household contamination.
Afoksolaner ubije bolhe preden lahko izležejo jajčeca, zato preprečuje kontaminacijo okolice z razvojnimi oblikami.
No adverse reactions were observed in eight-week old healthy puppies after 6 treatments at up to 5 times the maximum dose.
Pri zdravih mladičih pasme beagle, starih 8 tednov in več niso opazili nobenih neželenih učinkov med 6-kratnim zdravljenjem s 5-kratnikom največjega odmerka.
Fleas and ticks need to start feeding on the host to become exposed to afoxolaner; therefore the risk of the transmission of vector-borne diseases cannot be excluded.
Paraziti se morajo začeti hraniti na gostitelju, da pridejo v stik z afoksolanerom, zato prenosa bolezni, ki se prenašajo s paraziti, ni mogoče izključiti.
Further treatments may be indicated throughout the flea and/or tick season.
Ponovitev zdravljenja je lahko potrebna skozi celotno obdobje sezone bolh in klopov.
NEXGARD SPECTRA can be used as part of the seasonal treatment of fleas and ticks (replacing treatment with a monovalent flea and tick product) in dogs with diagnosed concurrent gastrointestinal nematode infestations.
Zdravilo NEXGARD SPECTRA je lahko del sezonskega zdravljenja bolhavosti in klopavosti (zamenjava za monovalentno zdravilo proti bolham in klopom) pri psih, ki jim je bila diagnosticirana infestacija z gastrointestinalnimi nematodi.
Parasite resistance to any particular class of parasiticides may develop following the frequent, repeated use of a product of that class.
Pri pogosti uporabi antiparazitikov kateregakoli razreda lahko pride do odpornosti parazitov na učinkovino tega razreda.
NEXGARD SPECTRA can be used as part of the seasonal treatment of fleas and ticks (replacing a product authorised for the treatment of fleas/ticks only) in dogs with diagnosed concurrent gastrointestinal worm infestations.
Zdravilo NEXGARD SPECTRA je lahko del sezonskega zdravljenja bolhavosti in klopavosti (zamenjava za zdravilo, ki deluje samo proti bolham in klopom) pri psih, ki jim je bila diagnosticirana sočasna infestacija z gastrointestinalnimi glistami.
Each chewable tablet contains 9.375 mg afoxolaner and 1.875 mg milbemycin oxime Each chewable tablet contains 18.75 mg afoxolaner and 3.75 mg milbemycin oxime Each chewable tablet contains 37.5 mg afoxolaner and 7.5 mg milbemycin oxime Each chewable tablet contains 75 mg afoxolaner and 15 mg milbemycin oxime Each chewable tablet contains 150 mg afoxolaner and 30 mg milbemycin oxime
Vsaka žvečljiva tableta vsebuje 9,375 mg afoksolanera in 1,875 mg milbemicin oksima Vsaka žvečljiva tableta vsebuje 18,75 mg afoksolanera in 3,75 mg milbemicin oksima Vsaka žvečljiva tableta vsebuje 37,5 mg afoksolanera in 7,5 mg milbemicin oksima Vsaka žvečljiva tableta vsebuje 75 mg afoksolanera in 15 mg milbemicin oksima Vsaka žvečljiva tableta vsebuje 150 mg afoksolanera in 30 mg milbemicin oksima
The selective toxicity of afoxolaner between insects, acarines and mammals may be inferred by the differential sensitivity of the insects and acarines' GABA receptors versus mammalian GABA receptors.
Sklepa se, da je selektivna toksičnost učinkovine afoksolaner drugačna pri insektih/pršicah in sesalcih zaradi razlike v občutljivosti GABA receptorjev.
EU/2/14/177/007 - 38 mg/ 8 mg, 1 chewable tablet EU/2/14/177/008 - 38 mg/ 8 mg, 3 chewable tablets EU/2/14/177/009 - 38 mg/ 8 mg, 6 chewable tablets EU/2/14/177/018 - 38 mg/ 8 mg, 15 chewable tablets EU/2/14/177/010 - 75 mg/ 15 mg, 1 chewable tablet EU/2/14/177/011 - 75 mg/ 15 mg, 3 chewable tablets EU/2/14/177/012 - 75 mg/ 15 mg, 6 chewable tablets EU/2/14/177/019 - 75 mg/ 15 mg, 15 chewable tablets EU/2/14/177/013 -150 mg/ 30 mg, 1 chewable tablet EU/2/14/177/014 -150 mg/ 30 mg, 3 chewable tablets EU/2/14/177/015 -150 mg/ 30 mg, 6 chewable tablets EU/2/14/177/020 -150 mg/ 30 mg, 15 chewable tablets
EU/2/14/177/008 - 38 mg/ 8 mg, 3 žvečljive tablete EU/2/14/177/009 - 38 mg/ 8 mg, 6 žvečljivih tablet EU/2/14/177/018 - 38 mg/ 8 mg, 15 žvečljivih tablet EU/2/14/177/010 - 75 mg/ 15 mg, 1 žvečljiva tableta EU/2/14/177/011 - 75 mg/ 15 mg, 3 žvečljive tablete EU/2/14/177/012 - 75 mg/ 15 mg, 6 žvečljivih tablet EU/2/14/177/019 - 75 mg/ 15 mg, 15 žvečljivih tablet EU/2/14/177/013 -150 mg/ 30 mg, 1 žvečljiva tableta EU/2/14/177/014 -150 mg/ 30 mg, 3 žvečljive tablete EU/2/14/177/015 -150 mg/ 30 mg, 6 žvečljivih tablet EU/2/14/177/020 -150 mg/ 30 mg, 15 žvečljivih tablet
Ancylostoma ceylanicum is reported as being endemic only in Southeast Asia, China, India, Japan, some Pacific islands, Australia, the Arab Peninsula, South Africa and South America.
Ancylostoma ceylanicum je poročana kot endemična samo v jugovzhodni Aziji, na Kitajskem, v Indiji,
Therefore, the use of this product should be based on the assessment of each individual case and on local epidemiological information about the current susceptibility of the target species in order to limit the possibility of a future selection for resistance.
Zato je potrebno upoštevati epidemiološke podatke o trenutni občutljivosti ciljnih organizmov, da se zmanjša verjetnost nastanka kasnejše selekcionirane rezistence.
These occurrences were generally self-limiting and of short duration.
Ti neželeni učinki so prehodnega značaja in minejo sami od sebe.
Prevention of establishment of thelaziosis (adult Thelazia callipaeda eyeworm infection) with monthly administration.
Preprečevanje razvoja telazioze (okužba z odraslimi očesnimi črvi Thelazia callipaeda) z mesečnim dajanjem zdravila.
EU/2/14/177/001 - 9 mg/ 2 mg, 1 chewable tablet EU/2/14/177/002 - 9 mg/ 2 mg, 3 chewable tablets EU/2/14/177/003 - 9 mg/ 2 mg, 6 chewable tablets EU/2/14/177/016 - 9 mg/ 2 mg, 15 chewable tablets EU/2/14/177/004 - 19 mg/ 4 mg, 1 chewable tablet EU/2/14/177/005 - 19 mg/ 4 mg, 3 chewable tablets EU/2/14/177/006 - 19 mg/ 4 mg, 6 chewable tablets EU/2/14/177/017 - 19 mg/ 4 mg, 15 chewable tablets
EU/2/14/177/001 - 9 mg/ 2 mg, 1 žvečljiva tableta EU/2/14/177/002 - 9 mg/ 2 mg, 3 žvečljive tablete EU/2/14/177/003 - 9 mg/ 2 mg, 6 žvečljivih tablet EU/2/14/177/016 - 9 mg/ 2 mg, 15 žvečljivih tablet EU/2/14/177/004 - 19 mg/ 4 mg, 1 žvečljiva tableta EU/2/14/177/005 - 19 mg/ 4 mg, 3 žvečljive tablete EU/2/14/177/006 - 19 mg/ 4 mg, 6 žvečljivih tablet EU/2/14/177/017 - 19 mg/ 4 mg, 15 žvečljivih tablet EU/2/14/177/007 - 38 mg/ 8 mg, 1 žvečljiva tableta
Efficacy of the treatment against flea and tick infestations lasts for one month.
Zdravilo učinkuje na bolhe in klope en mesec.
Prevention of angiostrongylosis (by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum) with monthly administration.
Preprečevanje angiostrongiloze (z zmanjšanjem stopnje infestiranosti z nezrelimi odraslimi (L5) in odraslimi oblikami Angiostrongylus vasorum) z mesečnim dajanjem zdravila.
No therapeutic effect against adult Dirofilaria immitis has been established.
Zdravilo nima terapevtskega učinka na odrasle srčen gliste.
Fleas and ticks need to start feeding on the host to become exposed to the substance afoxolaner; therefore the risk of the transmission of diseases by fleas and ticks cannot be excluded.
Paraziti se morajo začeti hraniti, da pridejo v stik z zdravilno učinkovino afoksolaner, zato prenosa bolezni, ki jih prenašajo bolhe in klopi ni mogoče povsem izključiti.
Dogs 2-3.5 kg Dogs >3.5-7.5 kg Dogs >7.5-15 kg Dogs >15-30 kg Dogs >30-60 kg
Psi 2 3,5 kg Psi >3,5 7,5 kg Psi >7,5-15 kg Psi >15-30 kg Psi >30-60 kg
It is active against adult fleas as well as against several tick species such as Rhipicephalus sanguineus, Dermacentor reticulatus and D. variabilis, Ixodes ricinus and I. scapularis, Amblyomma americanum, and Haemaphysalis longicornis.
Učinkuje na odrasle bolhe kot tudi številne vrste klopov, kot so Rhipicephalus sanguineus, Dermacentor reticulatus in D. variabilis, Ixodes ricinus and I. scapularis, Amblyomma americanum, in Haemaphysalis longicornis.
In regions where heartworm disease is present, dogs should be tested for existing heartworm infestation prior to administration of NEXGARD SPECTRA.
Na območjih, kjer je bolezen srčne gliste prisotna, bi bilo potrebno pred zdravljenjem z zdravilom NEXGARD SPECTRA pri psih diagnosticirati morebitne obstoječe infestacije.
Laboratory studies in rats and rabbits have not produced any evidence of birth defects, or any adverse effect on the reproductive capacity in males and females.
Brejost in laktacija: Z laboratorijskimi študijami na podganah in kuncih niso bili dokazani škodljivi učinki na plod ali drugi neželeni učinki na reproduktivno sposobnost samcev in samic.
Treatment of tick infestations (Dermacentor reticulatus, Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus) in dogs for 4 weeks.
Zdravljenje infestacije s klopi pri psih (Dermacentor reticulatus, Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus) traja do 4 tedne.
When replacing another heartworm preventative product in a heartworm prevention programme, the first treatment with NEXGARD SPECTRA should start on the date when the former medication was due to have been administered.
V primeru menjave drugega zdravila, ki preprečuje okužbe s srčno glisto, se odmeri prvi odmerek zdravila NEXGARD SPECTRA na dan, ko bi žival morala prejeti naslednji odmerek prejšnjega zdravila.
Treatment of tick infestations (Dermacentor reticulatus, Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus) in dogs.
Zdravljenje infestacije s klopi (Dermacentor reticulatus, Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus) pri psih.
Treatment of flea infestations (Ctenocephalides felis and C. canis) in dogs for 5 weeks.
Zdravljenje infestacije z bolhami pri psih (Ctenocephalides felis and C. canis) traja do 5 tednov.
Name and address of the manufacturer(s) responsible for batch release
Ime in naslov proizvajalca zdravila, odgovornega za sproščanje serij
Monthly administration of the product prevents establishment of infection with adult Thelazia callipaeda eyeworm.
Preprečevanje telazioze: Mesečno odmerjanje zdravila prepreči razvoj okužbe z odraslimi očesnimi črvi Thelazia callipaeda.
For each strength, the chewable tablets are available in the following pack sizes: Carton with 1 thermoformed blister containing 1, 3 or 6 chewable tablets or 15 thermoformed blisters containing 1 chewable tablet.
Škatla z 1 pretisnim toplotno oblikovanim omotom z 1, 3 ali 6 žvečljivimi tabletami ali s 15 toplotno oblikovanimi pretisnimi omoti z 1 žvečljivo tableto.
A single treatment is effective for the treatment of gastrointestinal nematodes.
Za učinkovito zdravljenje gastrointestinalnih nematodov zadošča enkratno dajanje zdravila.
Treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (Toxocara canis and Toxascaris leonina), hookworms (Ancylostoma caninum, Ancylostoma braziliense and Ancylostoma ceylanicum) and whipworm (Trichuris vulpis).
Zdravljenje infestacij z odraslimi gastrointestinalnimi nematodi naslednjih vrst: valjasti črvi (Toxocara canis in Toxascaris leonina), kavljasti črvi ( Ancylosotma caninum, Ancylostoma brazilienze in Ancylostoma ceylanicum), in bičeglavci (Trichuris vulpis).
Mottled red to reddish brown, circular shaped (tablets for dogs 2-3.5 kg) or rectangular shaped (tablets for dogs >3.5-7.5 kg, tablets for dogs >7.5-15 kg, tablets for dogs >15-30 kg and tablets for dogs >30-60 kg).
Lisasto rdeče do rdečkasto rjave, okrogle (tablete za pse 2-3,5 kg) ali pravokotno oblikovane tablete (tablete za pse >3,5-7,5 kg, tablete za pse >7,5-15 kg, tablete za pse >15-30 kg in tablete za pse > 30-60 kg).
The veterinary medicinal product should be administered in accordance with the following table:
Zdravilo uporabljajte glede na spodnjo tabelo:
For the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (Dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (L5) and adults of Angiostrongylus vasorum), thelaziosis (adult Thelazia callipaeda) and/or treatment of gastrointestinal nematode infestations is indicated.
Zdravljenje infestacije z bolhami in klopi pri psih, kjer je indicirano sočasno preprečevanje srčne gliste (ličinke Dirofilaria immitis), angiostrongiloze (zmanjšanje stopnje infestiranosti z nezrelimi odraslimi (L5) in odraslimi oblikami Angiostrongylus vasorum), telazioze (odrasli Thelazia callipaeda) in /ali zdravljenje infestacije z gastrointestinalnimi nematodi.
Further monthly administrations of the product may be required based on clinical assessment and skin scrapings.
Na podlagi klinične ocene in kožnega ostružka je lahko potrebno z mesečnim zdravljenjem še nadaljevati.
Milbemycin oxime is active against several gastrointestinal worms (Toxocara canis, Toxascaris leonina, Ancylostoma caninum, Ancylostoma braziliense, Ancylostoma ceylanicum, Trichuris vulpis), the adults and immature adults (L5) of lungworm Angiostrongylus vasorum and heartworm (Dirofilaria immitis larvae).
Milbemicin oksim deluje na več vrst gastrointestinalnih parazitov (Toxacara canis, Toxascaris leonina, Ancylostoma caninum, Ancylostoma braziliense, Ancylostoma ceylanicum, Trichuris vulpis), na odrasle in nezrele odrasle (L5) pljučnih črvov Angiostrongylus vasorum in srčne gliste (ličinke Dirofilaria immitis).
It is active against several gastrointestinal worms (Toxocara canis, Toxascaris leonina, Ancylostoma caninum, Ancylostoma braziliense, Ancylostoma ceylanicum, Trichuris vulpis), the adults and immature adults (L5) of lungworm Angiostrongylus vasorum and larvae of the heartworm Dirofilaria immitis.
Deluje na številne gastrointestinalne gliste(Toxocara canis in Toxascaris leonina, Ancylosotma caninum, Ancylostoma brazilienze, Ancylostoma ceylanicum, Trichuris vulpis), na odrasle in nezrele odrasle (L5) pljučnih črvov Angiostrongylus vasorum in srčne gliste (ličinke Dirofilaria immitis).
In heartworm endemic areas, dogs should be tested for existing heartworm infestation prior to administration of NEXGARD SPECTRA.
V endemičnih področjih dirofilarioze bi bilo potrebno pred zdravljenjem z zdravilom NEXGARD SPECTRA pri psih diagnosticirati morebitne obstoječe infestacije s srčno glisto.
Ancylostoma ceylanicum is reported as being endemic only in South-East Asia, China, India, Japan, some Pacific islands, Australia, the Arab Peninsula, South Africa and South America.
na Japonskem, na nekaterih Pacifiških otokih, v Avstraliji, na Arabskem polotoku, v Južni Afriki in Južni Ameriki.
The recommended dose should be strictly observed in collies or related breeds.
Pri psih pasem coli in sorodnih pasmah se je potrebno striktno držati priporočenih odmerkov.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Outer carton
PODATKI NA ZUNANJI OVOJNINI Škatla
Chewable tablets Read the package leaflet before use.
- Tablete hranite v pretisnem omotu do uporabe.
NEXGARD SPECTRA kills Dirofilaria immitis larvae (heartworm) up to one month after their transmission by mosquitoes.
Zdravilo NEXGARD SPECTRA ubija ličinke Dirofilaria immitis do enega meseca po njihovem prenosu s komarji, zato je potrebno zdravilo odmerjati redno v mesečnih intervalih v celotnem obdobju izpostavljenosti komarjem.
A single treatment is effective for gastrointestinal worms.
Za učinkovito zdravljenje gastrointestinalnih glist zadošča enkratno dajanje zdravila.
- Keep tablets in the blister packs until required, and keep the blisters in the outer carton.
- Tablete hranite v omotu do uporabe.
At the discretion of the veterinarian, infested dogs should be treated with an adulticide to remove adult heartworms.
Odpravljanje ugotovljenih odraslih srčnih glist je odgovornost lečečega veterinarja.
Macrogol 4000
31300 Toulouse
Vomiting, diarrhoea, lethargy, anorexia, and pruritus were uncommonly observed.
Redko so bili opaženi bruhanje, driska, letargija, neješčnost in srbečica.
NEXGARD SPECTRA 9 mg/ 2 mg dogs 2-3.5 kg NEXGARD SPECTRA 19 mg/ 4 mg dogs >3.5-7.5 kg NEXGARD SPECTRA 38 mg/ 8 mg dogs >7.5-15 kg NEXGARD SPECTRA 75 mg/ 15 mg dogs >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg dogs >30-60 kg afoxolaner / milbemycin oxime Tablets
NEXGARD SPECTRA 9 mg/ 2 mg psi 2-3,5 kg NEXGARD SPECTRA 19mg/ 4 mg psi >3,5 -7,5 kg NEXGARD SPECTRA 38 mg/ 8 mg psi >7,5 -15 kg NEXGARD SPECTRA 75 mg/ 15 mg psi >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg psi >30-60 kg afoxolaner/milbemicyn oxime tablete
METHOD AND ROUTE(S) OF ADMINISTRATION
NAČIN IN POT(I) UPORABE Žvečljive tablete
NEXGARD SPECTRA 9 mg/ 2 mg chewable tablets for dogs 2-3.5 kg NEXGARD SPECTRA 19 mg/ 4 mg chewable tablets for dogs >3.5-7.5 kg NEXGARD SPECTRA 38 mg/ 8 mg chewable tablets for dogs >7.5-15 kg NEXGARD SPECTRA 75 mg/ 15 mg chewable tablets for dogs >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg chewable tablets for dogs >30-60 kg afoxolaner / milbemycin oxime
NEXGARD SPECTRA 9 mg/ 2 mg žvečljive tablete za pse 2-3,5 kg NEXGARD SPECTRA 19mg/ 4 mg žvečljive tablete za pse >3,5-7,5 kg NEXGARD SPECTRA 38 mg/ 8 mg žvečljive tablete za pse >7,5 -15 kg NEXGARD SPECTRA 75 mg/ 15 mg žvečljive tablete za pse >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg žvečljive tablete za pse >30-60 kg afoxolaner/milbemycin oxime
Prevention of heartworm disease (Dirofilaria immitis larvae) with monthly administration.
Preprečevanje razvoja srčne gliste (Dirofilaria immitis ličinke) z odmerjanjem enkrat mesečno.
NEXGARD SPECTRA 9 mg / 2 mg chewable tablets for dogs 2-3.5 kg NEXGARD SPECTRA 19 mg / 4 mg chewable tablets for dogs >3.5-7.5 kg NEXGARD SPECTRA 38 mg / 8 mg chewable tablets for dogs >7.5-15 kg NEXGARD SPECTRA 75 mg / 15 mg chewable tablets for dogs >15-30 kg NEXGARD SPECTRA 150 mg / 30 mg chewable tablets for dogs >30-60 kg
NEXGARD SPECTRA 9 mg/ 2 mg žvečljive tablete za pse 2-3,5 kg NEXGARD SPECTRA 19mg/ 4 mg žvečljive tablete za pse >3,5-7,5 kg NEXGARD SPECTRA 38 mg/ 8 mg žvečljive tablete za pse >7,5-15 kg NEXGARD SPECTRA 75 mg/ 15 mg žvečljive tablete za pse >15-30 kg
Treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis):
Zdravljenje garjavosti (ki jo povzroča Sarcoptes scabiei var. canis): Dajanje enkrat mesečno dva zaporedna meseca.
Maintenance of the efficacy of macrocyclic lactones is critical for Dirofilaria immitis control.
Vzdrževanje učinkovitosti makrolitičnih laktonov je kritičnega pomena za nadzor nad Dirofilaria immitis.Za zmanjšanje možnosti pojava selekcije rezistence, je priporočljivo diagnosticiranje tako prostih antigenov kot mikrofilarij v krvi pri psih na začetku vsake sezone preventivnega zdravljenja.
NEXGARD SPECTRA 9 mg / 2 mg chewable tablets for dogs 2-3.5 kg NEXGARD SPECTRA 19 mg / 4 mg chewable tablets for dogs >3.5-7.5 kg NEXGARD SPECTRA 38 mg / 8 mg chewable tablets for dogs >7.5-15 kg NEXGARD SPECTRA 75 mg / 15 mg chewable tablets for dogs >15-30 kg NEXGARD SPECTRA 150 mg / 30 mg chewable tablets for dogs >30-60 kg Afoxolaner, milbemycin oxime
NEXGARD SPECTRA 19mg/ 4 mg žvečljive tablete za pse >3,5-7,5 kg NEXGARD SPECTRA 38 mg/ 8 mg žvečljive tablete za pse >7,5 -15 kg NEXGARD SPECTRA 75 mg/ 15 mg žvečljive tablete za pse >15-30 kg NEXGARD SPECTRA 150 mg/ 30 mg žvečljive tablete za pse >30-60 kg afoksolaner, milbemicin oksim
0,3 mg/1 m Solution for Injection Intravenous use
0,3 mg/1 m Raztopina za injiciranje Intravenska uporaba
Prolonged-Release Capsule, hard
Kapsula s podaljšanim sproščanjem, trda
Dihydroergocryptine containing medicinal products with Marketing Authorisation in the European Union
Zdravila, ki vsebujejo dihidroergokriptin, z dovoljenjem za promet z zdravili v Evropski uniji
Lisuride containing medicinal products with Marketing Authorisation in the European Union
Zdravila, ki vsebujejo lizurid, z dovoljenjem za promet z zdravili v Evropski uniji
Film-coated Tablet
Filmsko obložena tableta Peroralna uporaba
Powder for Injection
Prašek za raztopino za injiciranje intramuskularna uporaba
Gastro-Resistant Tablet
Gastrorezistentna tableta Peroralna uporaba
Prolonged-Release Tablet
Tableta s podaljšanim sproščanjem
Solution for Injection Oral Use
Raztopina za injiciranje Peroralna uporaba
Bromokin scored tablet
Šumeča tableta
Bromocriptine containing medicinal products with Marketing Authorisation in the European Union
Zdravila, ki vsebujejo bromokriptin, z dovoljenjem za promet z zdravili v Evropski uniji Država članica Imetnik dovoljenja za promet z zdravilom Izmišljeno ime
Oral Drops
Peroralne kapljice
<Content (concentration)>
Vsebina (koncentracija)
3 pre-filled syringes + 3 needles
3 ml (10 mg/ml) 3 napolnjene injekcijske brizge + 3 igle
1 pre-filled syringe + 1 needle
3 ml (10 mg/ml) 1 napolnjena injekcijska brizga + 1 igla
MA (EU) number (Invented) name Strength Pharmaceutical form
Številka (EU) dovoljenja za promet
European Medicines Agency Veterinary Medicines
Farmacevtska oblika
7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 84 47 E-mail: mail@emea.europa.eu http://www.emea.europa.eu©EMEA 2007 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged
EU/2/99/011/001 Locatim >2.8log10 /ml goveji koncentrirani laktoserum
©EMEA 2007
Karenca
Locatim is an oral solution produced from colostrum which is given to calves in the first 12 hours of life.
Novorojena teleta do 12 ur starosti.
Information on the prescription status of this product may be found on the label/outer package.
Ovojnina Vsebina Velikost pakiranja
What is Locatim?
Peroralna raztopina
Locatim is presented in a 60 ml glass bottle.
1 Stekleničko stekla
These adverse effects are listed below.
Ti neželeni učinki so navedeni spodaj.
Tell your doctor promptly about these or any other unusual symptoms.
Svojega zdravnika takoj obvestite o teh ali katerih koli drugih nenavadnih simptomih.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 07/05/1999
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum prve pridobitve dovoljenja: 07/05/1999
- This vaccine has been prescribed for your child and you should not pass it on to others.
- Cepivo je bilo predpisano vašemu otroku in ga ne smete dajati drugim.
If the condition persists or worsens, seek medical attention.
Če stanje traja dalje ali se poslabša, poiščite zdravniško pomoč.
Official batch release: in accordance with Article 114 Directive 2001/83/EEC, the official batch release will be undertaken by a state laboratory or a laboratory disignated for that purpose.
Uradna sprostitev serije: v skladu s členom 114 Direktive 2001/83/ES, serijo uradno sprosti državni laboratorij ali laboratorij, določen v ta namen.